LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 211 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,044,160 | +39.9% | 46,154 | +77.2% | 0.04% | +2.5% |
| Q1 2024 | $1,460,639 | -80.0% | 26,041 | -78.6% | 0.04% | -83.5% |
| Q4 2023 | $7,309,512 | +130.5% | 121,481 | +157.3% | 0.24% | +100.0% |
| Q3 2023 | $3,171,029 | +0.0% | 47,209 | +2.8% | 0.12% | +1.7% |
| Q2 2023 | $3,170,893 | +34.9% | 45,935 | -2.5% | 0.12% | -4.8% |
| Q4 2022 | $2,351,232 | -31.6% | 47,100 | -44.1% | 0.12% | -7.4% |
| Q3 2022 | $3,439,000 | +171.2% | 84,300 | +141.6% | 0.14% | +145.5% |
| Q1 2022 | $1,268,000 | -39.0% | 34,893 | -15.1% | 0.06% | -63.3% |
| Q3 2021 | $2,079,000 | +43.9% | 41,116 | +16.8% | 0.15% | +7.1% |
| Q2 2021 | $1,445,000 | – | 35,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |